Company · CIK 0001232524 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Jazz Pharmaceuticals plc · JAZZ
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 SForm 4 → | Sep 14, 6:38 pm EDT | Neena M PatilEVP & Chief Legal Officer | 1,200 | $240.94 | $289,128 | 47,671 | −2.46% | 10b5-1 |
| Sep 8, 2026 SForm 4 → | Sep 10, 4:33 pm EDT | Renee D GalaPresident & CEO | 2,000 | $243.03 | $486,060 | 143,394 | −1.38% | 10b5-1 |
| Sep 8, 2026 FForm 4 → | Sep 10, 4:33 pm EDT | Renee D GalaPresident & CEO | 1,967 | $246.81 | $485,475 | 145,394 | — | 10b5-1 |
| Sep 8, 2026 FForm 4 → | Sep 10, 4:28 pm EDT | Mary Elizabeth HendersonSVP, Technical Operations | 1,427 | $243.01 | $346,776 | 23,815 | — | |
| Sep 1, 2026 SForm 4 → | Sep 2, 5:03 pm EDT | Bruce C CozaddDirector | 6,000 | $250.13 | $1,500,780 | 351,875 | −1.68% | 10b5-1 |
| Aug 31, 2026 FForm 4 → | Sep 2, 5:38 pm EDT | Mary Elizabeth HendersonSVP, Technical Operations | 2,092 | $241.41 | $505,040 | 25,242 | — | |
| Aug 31, 2026 FForm 4 → | Sep 2, 5:34 pm EDT | Mark Douglas SmithDirector | 1,706 | $241.42 | $411,857 | 9,579 | — | |
| Aug 31, 2026 FForm 4 → | Sep 2, 5:31 pm EDT | Norbert G RiedelDirector | 1,706 | $241.42 | $411,857 | 6,923 | — | |
| Aug 31, 2026 FForm 4 → | Sep 2, 5:28 pm EDT | Ted W LoveDirector | 743 | $241.41 | $179,369 | 2,389 | — | |
| Aug 31, 2026 FForm 4 → | Sep 2, 5:24 pm EDT | Laura HamillDirector | 1,706 | $241.41 | $411,849 | 6,832 | — | |
| Aug 31, 2026 FForm 4 → | Sep 2, 5:20 pm EDT | Jennifer E. CookDirector | 1,706 | $241.41 | $411,849 | 10,736 | — | |
| Aug 31, 2026 FForm 4 → | Sep 2, 5:17 pm EDT | Patrick G EnrightDirector | 1,706 | $241.42 | $411,857 | 21,278 | — | |
| Aug 31, 2026 FForm 4 → | Sep 2, 5:13 pm EDT | Heather Ann McSharryDirector | 1,855 | $241.42 | $447,827 | 18,199 | — | |
| Aug 31, 2026 FForm 4 → | Sep 2, 5:09 pm EDT | Patrick KennedyDirector | 1,855 | $241.41 | $447,819 | 6,452 | — | |
| Aug 31, 2026 FForm 4 → | Sep 2, 5:06 pm EDT | Rick E WinninghamDirector | 1,706 | $241.42 | $411,857 | 9,466 | — | |
| Aug 31, 2026 FForm 4 → | Sep 2, 5:03 pm EDT | Bruce C CozaddDirector | 1,219 | $241.41 | $294,281 | 357,875 | — | 10b5-1 |
| Aug 27, 2026 SForm 4 → | Aug 31, 6:45 pm EDT | Robert IannoneEVP, Global Head of R&D & CMO | 76,921 | $249.70 | $19,207,098 | 65,686 | −53.9% | 10b5-1 |
| Aug 27, 2026 MForm 4 → | Aug 31, 6:45 pm EDT | Robert IannoneEVP, Global Head of R&D & CMO | 57,500 | $125.84 | $7,235,860 | 142,607 | — | 10b5-1 |
| Aug 5, 2026 FForm 4 → | Aug 7, 6:01 pm EDT | Samantha PearceEVP, Chief Commercial Officer | 780 | $261.62 | $204,064 | 47,131 | — | |
| Aug 5, 2026 AForm 4 → | Aug 7, 5:57 pm EDT | Rick E WinninghamDirector | 1,605 | — | — | 11,172 | — | |
| Aug 5, 2026 AForm 4 → | Aug 7, 5:55 pm EDT | Ted W LoveDirector | 1,605 | — | — | 3,132 | — | |
| Aug 5, 2026 AForm 4 → | Aug 7, 5:50 pm EDT | Laura HamillDirector | 1,605 | — | — | 8,538 | — | |
| Aug 5, 2026 AForm 4 → | Aug 7, 5:48 pm EDT | Patrick KennedyDirector | 1,605 | — | — | 8,307 | — | |
| Aug 5, 2026 AForm 4 → | Aug 7, 5:46 pm EDT | Mark Douglas SmithDirector | 1,605 | — | — | 11,285 | — | |
| Aug 5, 2026 AForm 4 → | Aug 7, 5:44 pm EDT | Jennifer E. CookDirector | 1,605 | — | — | 12,442 | — | |
| Aug 5, 2026 AForm 4 → | Aug 7, 5:42 pm EDT | Seamus MulliganDirector | 1,605 | — | — | 1,184,633 | — | |
| Aug 5, 2026 AForm 4 → | Aug 7, 5:39 pm EDT | Heather Ann McSharryDirector | 1,605 | — | — | 20,054 | — | |
| Aug 5, 2026 AForm 4 → | Aug 7, 5:37 pm EDT | Patrick G EnrightDirector | 1,605 | — | — | 22,984 | — | |
| Aug 5, 2026 AForm 4 → | Aug 7, 5:33 pm EDT | Norbert G RiedelDirector | 1,605 | — | — | 8,629 | — | |
| Aug 5, 2026 AForm 4 → | Aug 7, 5:31 pm EDT | Bruce C CozaddDirector | 1,605 | — | — | 362,287 | — | |
| Aug 3, 2026 SForm 4 → | Aug 5, 4:33 pm EDT | Bruce C CozaddDirector | 6,000 | $252.98 | $1,517,880 | 360,682 | −1.64% | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 6, 6:23 pm EDT | Bruce C CozaddDirector | 6,000 | $240.47 | $1,442,820 | 366,682 | −1.61% | 10b5-1 |
| Jun 30, 2026 FForm 4 → | Jul 2, 6:27 pm EDT | Samantha PearceEVP, Chief Commercial Officer | 2,527 | $237.72 | $600,718 | 47,911 | — | |
| Jun 30, 2026 FForm 4 → | Jul 2, 6:21 pm EDT | Renee D GalaPresident & CEO | 4,835 | $237.72 | $1,149,376 | 147,361 | — | |
| Jun 30, 2026 FForm 4 → | Jul 2, 6:16 pm EDT | Robert IannoneEVP, Global Head of R&D & CMO | 3,764 | $237.72 | $894,778 | 85,107 | — | |
| Jun 30, 2026 FForm 4 → | Jul 2, 6:09 pm EDT | Neena M PatilEVP & Chief Legal Officer | 2,678 | $237.72 | $636,614 | 48,871 | — | |
| Jun 30, 2026 FForm 4 → | Jul 2, 6:04 pm EDT | Philip L JohnsonEVP & Chief Financial Officer | 3,343 | $237.72 | $794,698 | 56,431 | — | |
| Jun 15, 2026 SForm 4 → | Jun 17, 4:45 pm EDT | Mark Douglas SmithDirector | 1,157 | $230.55 | $266,746 | 9,680 | −10.7% | 10b5-1 |
| Jun 10, 2026 SForm 4 → | Jun 12, 4:14 pm EDT | Neena M PatilEVP & Chief Legal Officer | 1,200 | $231.83 | $278,196 | 51,549 | −2.27% | 10b5-1 |
| Jun 3, 2026 GForm 4 → | Jun 5, 4:40 pm EDT | Renee D GalaPresident & CEO | 600 | — | — | 152,196 | — | |
| Jun 1, 2026 SForm 4 → | Jun 3, 5:09 pm EDT | Bruce C CozaddDirector | 6,000 | $235.12 | $1,410,720 | 372,682 | −1.58% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 27, 2026 MForm 4 → | Aug 31, 6:45 pm EDT | Robert IannoneEVP, Global Head of R&D & CMO | 57,500 | — | — | 0 | — | 10b5-1 |